Uberti-Foppa, C., De Bona, A. and Morsica, G., (2003) Pretreatment of chronic active hepatitis C in patients co- infected with HIV and hepatitis C virus reduces the he- patotoxicity associated with subsequent antiretroviral therapy. Journal of Acquired Immune Deficiency Syn- dromes, 33, 146-152. doi:10.1097/00126334-200306010-00005

has been cited by the following article:

• TITLE: Treatment of pulmonary coccidioidomycosis after successful hepatitis C therapy in a patient with fluconazole induced hepatotoxicity

  AUTHORS: Zohreh Movahedi, David Wisinger, Sorin Petre, Jyotsna Ravi, Thomas Ardiles, Renee Prevette, Ali Al-Yaqoobi, Abdul Nadir

  KEYWORDS: Coccidioidomycosis, Fluconazole, Hepatotoxicity

  JOURNAL NAME: Open Journal of Gastroenterology, Vol.2 No.1, February 16, 2012

  ABSTRACT: A patient with hepatitis C infection and cavitary pul- monary coccidioidomycosis is reported. Treatment of hepatitis C was associated with resolution of flucona- zole-induced hepatotoxicity. Successful treatment of he- patitis C enabled the patient to tolerate increaseing doses of fluconazole. This case highlights that hepatic toxicity of fluconazole can improve after successful treatment of hepatitis C.